{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:51:46Z","timestamp":1790610706959,"version":"4.1.0"},"reference-count":136,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["UM1AI104681"],"award-info":[{"award-number":["UM1AI104681"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1093\/jac\/dkx445","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T12:14:09Z","timestamp":1512476049000},"page":"i14-i25","source":"Crossref","is-referenced-by-count":83,"title":["What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead"],"prefix":"10.1093","volume":"73","author":[{"given":"Matteo","family":"Bassetti","sequence":"first","affiliation":[{"name":"Infectious Diseases Clinic, Department of Medicine University of Udine and Azienda Sanitaria Universitaria Integrata, Presidio Ospedaliero Universitario Santa Maria della Misericordia, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elda","family":"Righi","sequence":"additional","affiliation":[{"name":"Infectious Diseases Clinic, Department of Medicine University of Udine and Azienda Sanitaria Universitaria Integrata, Presidio Ospedaliero Universitario Santa Maria della Misericordia, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Montravers","sequence":"additional","affiliation":[{"name":"Paris Diderot Sorbonne Cite University, and Anesthesiology and Critical Care Medicine, Bichat-Claude Bernard University Hospital, HUPNSV, AP-HP, INSERM UMR 1152, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver A","family":"Cornely","sequence":"additional","affiliation":[{"name":"Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Department I of Internal Medicine, Clinical Trials Centre Cologne (ZKS K\u00f6ln), University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,1,3]]},"reference":[{"key":"key\n\t\t\t\t20180313122809_dkx445-B1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/infdis\/125.2.190","article-title":"Problems in the diagnosis and treatment of systemic candidiasis","volume":"125","author":"Goldstein","year":"1972","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/bmj.1.5643.577","article-title":"Candida septicaemia","volume":"1","author":"Appleyard","year":"1969","journal-title":"Br Med J"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B3","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJM196311212692102","article-title":"Systemic candida tropicalis infection treated with amphotericin","volume":"269","author":"Shurtleff","year":"1963","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B4","doi-asserted-by":"crossref","DOI":"10.1002\/cld.491","article-title":"Hepatosplenic candidiasis","volume":"6","author":"Cornely","year":"2015","journal-title":"Clin Liver Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.idc.2015.10.003","article-title":"Contemporary strategies in the prevention and management of fungal infections","volume":"30","author":"Koehler","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B6","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/cid\/civ707","article-title":"A randomized, placebo-controlled trial of preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for intra-abdominal infections","volume":"61","author":"Knitsch","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B7","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.2016.14655","article-title":"Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, Candida colonization, and multiple organ failure: the EMPIRICUS randomized clinical trial","volume":"316","author":"Timsit","year":"2016","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijid.2016.09.018","article-title":"Epidemiology, microbiology, clinical characteristics, and outcomes of candidemia in internal medicine wards-a retrospective study","volume":"52","author":"Eliakim-Raz","year":"2016","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2014.08.011","article-title":"Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006-2008)","volume":"21","author":"Klingspor","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B10","doi-asserted-by":"crossref","first-page":"21.","DOI":"10.1186\/1471-2334-6-21","article-title":"Epidemiological trends in nosocomial candidemia in intensive care","volume":"6","author":"Bassetti","year":"2006","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/tid.12613","article-title":"The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"18","author":"Andes","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/cid\/civ293","article-title":"Epidemiology and outcome of fungemia in a cancer cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031)","volume":"61","author":"Cornely","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B13","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"Reboli","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B15","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ1194","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B16","author":"Kullberg","year":"2016"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B17","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-017-4731-2","article-title":"Intensive care medicine research agenda on invasive fungal infection in critically ill patients","author":"Bassetti","year":"2017","journal-title":"Intensive Care Med"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B18","doi-asserted-by":"crossref","first-page":"ii13","DOI":"10.1093\/jac\/dkw392","article-title":"The current treatment landscape: candidiasis","volume":"71","author":"Bassetti","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B19","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials","volume":"54","author":"Andes","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B20","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199411173312001","article-title":"A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute","volume":"331","author":"Rex","year":"1994","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B21","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/374850","article-title":"A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects","volume":"36","author":"Rex","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B22","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B23","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(05)67490-9","article-title":"Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial","volume":"366","author":"Kullberg","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B24","author":"Reboli","year":"2005"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B25","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","article-title":"Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial","volume":"369","author":"Kuse","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B26","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1086\/520980","article-title":"Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis","volume":"45","author":"Pappas","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B27","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1001\/archinte.1988.00380120094019","article-title":"Hospital-acquired candidemia. The attributable mortality and excess length of stay","volume":"148","author":"Wey","year":"1988","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B28","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/378745","article-title":"Attributable mortality of nosocomial candidemia, revisited","volume":"37","author":"Gudlaugsson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B29","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1086\/514731","article-title":"Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)","volume":"28","author":"Viscoli","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B30","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0002-9343(02)01248-2","article-title":"Effects of nosocomial candidemia on outcomes of critically ill patients","volume":"113","author":"Blot","year":"2002","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B31","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s00134-017-4743-y","article-title":"The risk and clinical outcome of candidemia depending on underlying malignancy","volume":"43","author":"Lortholary","year":"2017","journal-title":"Intensive Care Med"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/myc.12207","article-title":"Our 2014 approach to candidaemia","volume":"57","author":"Koehler","year":"2014","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study","volume":"43","author":"Garey","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","article-title":"Guidelines for treatment of candidiasis","volume":"38","author":"Pappas","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10096-004-1103-y","article-title":"Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study","volume":"23","author":"Tortorano","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B36","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive candidiasis","volume":"373","author":"Kullberg","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B37","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1128\/AAC.01031-09","article-title":"Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species","volume":"53","author":"Mann","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B38","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.1128\/AAC.04134-14","article-title":"Abdominal candidiasis is a hidden reservoir of echinocandin resistance","volume":"58","author":"Shields","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/380637","article-title":"Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000","volume":"38","author":"Marchetti","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B40","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1128\/AAC.01217-06","article-title":"In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates","volume":"51","author":"Seifert","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B41","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jinf.2007.04.003","article-title":"Trends in candidemia and antifungal susceptibility in a university hospital in Northern Ireland 2001-2006","volume":"55","author":"Metwally","year":"2007","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B42","author":"Koehler","year":"2016"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B44","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.00722-15","article-title":"Draft genome sequence of a fluconazole-resistant Candida auris strain from a candidemia patient in India","volume":"3","author":"Sharma","year":"2015","journal-title":"Genome Announc"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13756-016-0132-5","article-title":"First hospital outbreak of the globally emerging Candida auris in a European hospital","volume":"5","author":"Schelenz","year":"2016","journal-title":"Antimicrob Resist Infect Control"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.riam.2016.11.002","article-title":"Nosocomial fungemia by Candida auris: first four reported cases in continental Europe","volume":"34","author":"Ruiz Gaitan","year":"2017","journal-title":"Rev Iberoam Micol"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B47","doi-asserted-by":"crossref","first-page":"514","DOI":"10.15585\/mmwr.mm6619a7","article-title":"Notes from the field: ongoing transmission of Candida auris in health care facilities\u2014United States, June 2016-May 2017","volume":"66","author":"Tsay","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B48","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.15585\/mmwr.mm6544e1","article-title":"Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus\u2014United States, May 2013-August 2016","volume":"65","author":"Vallabhaneni","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/cid\/ciw696","article-title":"Emergence of Candida auris: an international call to arms","volume":"64","author":"Clancy","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B50","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00134-012-2616-y","article-title":"Value of \u03b2-d-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions","volume":"38","author":"Leon","year":"2012","journal-title":"Intensive Care Med"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B51","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/cid\/cis200","article-title":"Performance of Candida real-time polymerase chain reaction, \u03b2-d-glucan assay, and blood cultures in the diagnosis of invasive candidiasis","volume":"54","author":"Nguyen","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B52","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1128\/JCM.02473-12","article-title":"Comparison of (1->3)-\u03b2-d-glucan, mannan\/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia","volume":"51","author":"Held","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B53","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1093\/jac\/dkv241","article-title":"Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment","volume":"70","author":"Martinez-Jimenez","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B54","doi-asserted-by":"crossref","first-page":"149.","DOI":"10.1186\/s13054-016-1324-3","article-title":"Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions","volume":"20","author":"Leon","year":"2016","journal-title":"Crit Care"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B55","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/MCC.0b013e32833e04df","article-title":"New nonculture-based methods for the diagnosis of invasive candidiasis","volume":"16","author":"Bille","year":"2010","journal-title":"Curr Opin Crit Care"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B56","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/JCM.01602-10","article-title":"PCR diagnosis of invasive candidiasis: systematic review and meta-analysis","volume":"49","author":"Avni","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B57","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1086\/528690","article-title":"A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults","volume":"46","author":"McMullan","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B58","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1093\/jac\/dku225","article-title":"Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients","volume":"69","author":"Fortun","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B59","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1469-0691.2009.02940.x","article-title":"Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood","volume":"16","author":"Wallet","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B60","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1348-0421.1996.tb03327.x","article-title":"Kinetics of anti-mannan antibodies useful in confirming invasive candidiasis in immunocompromised patients","volume":"40","author":"van Deventer","year":"1996","journal-title":"Microbiol Immunol"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B61","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.3390\/ijms12107038","article-title":"Candida colonization index in patients admitted to an ICU","volume":"12","author":"Caggiano","year":"2011","journal-title":"Int J Mol Sci"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B62","doi-asserted-by":"crossref","first-page":"R222.","DOI":"10.1186\/cc9365","article-title":"The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia","volume":"14","author":"Mikulska","year":"2010","journal-title":"Crit Care"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B63","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s00134-013-3109-3","article-title":"A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts","volume":"39","author":"Bassetti","year":"2013","journal-title":"Intensive Care Med"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B64","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00134-014-3281-0","article-title":"What's new in the clinical and diagnostic management of invasive candidiasis in critically ill patients","volume":"40","author":"Leon","year":"2014","journal-title":"Intensive Care Med"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B65","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkv419","article-title":"1,3-\u03b2-d-Glucan contamination of common antimicrobials","volume":"71","author":"Liss","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B66","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/myc.12432","article-title":"1,3-ss-d-Glucan concentrations in blood products predict false positive post-transfusion results","volume":"59","author":"Liss","year":"2016","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B67","doi-asserted-by":"crossref","first-page":"646.e5","DOI":"10.1016\/j.cmi.2016.05.020","article-title":"Lower sensitivity of serum (1,3)-\u03b2-d-glucan for the diagnosis of candidaemia due to Candida parapsilosis","volume":"22","author":"Mikulska","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B68","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1164\/rccm.201211-2069OC","article-title":"\u03b2-Glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis","volume":"188","author":"Tissot","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B69","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1007\/s00134-015-3922-y","article-title":"\u03b2-d-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis","volume":"41","author":"Martin-Mazuelos","year":"2015","journal-title":"Intensive Care Med"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B70","doi-asserted-by":"crossref","first-page":"e42282","DOI":"10.1371\/journal.pone.0042282","article-title":"\u03b2-d-Glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study","volume":"7","author":"Hanson","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B71","doi-asserted-by":"crossref","first-page":"R249","DOI":"10.1186\/cc10507","article-title":"Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1\u2013>3)-\u03b2-d-glucan assay, Candida score, and colonization index","volume":"15","author":"Posteraro","year":"2011","journal-title":"Crit Care"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B72","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/cid\/cis456","article-title":"1,3)-\u03b2-d-Glucan as a prognostic marker of treatment response in invasive candidiasis","volume":"55","author":"Jaijakul","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B73","doi-asserted-by":"crossref","first-page":"E122","DOI":"10.1111\/j.1469-0691.2012.03777.x","article-title":"Post-diagnostic kinetics of the (1 \u2013> 3)-\u03b2-d-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia","volume":"18","author":"Koo","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B74","doi-asserted-by":"crossref","first-page":"R135.","DOI":"10.1186\/cc13953","article-title":"Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation","volume":"18","author":"Poissy","year":"2014","journal-title":"Crit Care"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B75","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2334-11-60","article-title":"Clinical factors associated with a Candida albicans germ tube antibody positive test in intensive care unit patients","volume":"11","author":"Peman","year":"2011","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B76","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/mmy\/myt025","article-title":"Potential role of Candida albicans germ tube antibody in the diagnosis of deep-seated candidemia","volume":"52","author":"Martinez-Jimenez","year":"2014","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B77","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/cid\/ciu959","article-title":"T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial","volume":"60","author":"Mylonakis","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B78","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/myc.12205","article-title":"Comparative analysis of Gram's stain, PNA-FISH and Sepsityper with MALDI-TOF MS for the identification of yeast direct from positive blood cultures","volume":"57","author":"Gorton","year":"2014","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B79","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10096-016-2864-9","article-title":"Matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) for rapid identification of micro-organisms in the routine clinical microbiology laboratory","volume":"36","author":"Wattal","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B80","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/cid\/cit498","article-title":"Impact of rapid organism identification via matrix-assisted laser desorption\/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia","volume":"57","author":"Huang","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B81","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s15010-013-0558-0","article-title":"An Italian consensus for invasive candidiasis management (ITALIC)","volume":"42","author":"Scudeller","year":"2014","journal-title":"Infection"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B82","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B83","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/CCM.0b013e318236f297","article-title":"Systemic antifungal therapy in critically ill patients without invasive fungal infection","volume":"40","author":"Azoulay","year":"2012","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B84","first-page":"15","article-title":"Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study","volume":"6","author":"Wissing","year":"2013","journal-title":"Infect Drug Resist"},{"issue":"1","key":"key\n\t\t\t\t20180313122809_dkx445-B85","first-page":"CD004920","article-title":"Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients","author":"Cortegiani","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20180313122809_dkx445-B86","doi-asserted-by":"crossref","first-page":"i60","DOI":"10.1093\/jac\/dkx450","article-title":"Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies","volume":"73","author":"Epstein","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20180313122809_dkx445-B87","doi-asserted-by":"crossref","first-page":"i51","DOI":"10.1093\/jac\/dkx449","article-title":"Use of echinocandin prophylaxis in solid organ transplantation","volume":"73","author":"Giannella","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B88","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ijid.2008.10.013","article-title":"Invasive fungal infections and (1,3)-\u03b2-d-glucan serum concentrations in long-term intensive care patients","volume":"13","author":"Presterl","year":"2009","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B89","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1128\/JCM.01240-10","article-title":"Prospective survey of (1\u2013>3)-\u03b2-d-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting","volume":"49","author":"Mohr","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B90","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1155\/2010\/357076","article-title":"Canadian clinical practice guidelines for invasive candidiasis in adults","volume":"21","author":"Bow","year":"2010","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B91","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/cid\/ciu074","article-title":"MSG-01: a randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting","volume":"58","author":"Ostrosky-Zeichner","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B92","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7326\/0003-4819-149-2-200807150-00004","article-title":"Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial","volume":"149","author":"Schuster","year":"2008","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B93","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13613-015-0103-7","article-title":"Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study","volume":"6","author":"Leroy","year":"2016","journal-title":"Ann Intensive Care"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B94","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/AAC.01128-10","article-title":"Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients","volume":"55","author":"Lortholary","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B95","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.201409-1701OC","article-title":"Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients","volume":"191","author":"Bailly","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B96","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.clinthera.2014.06.028","article-title":"Effects of empiric antifungal therapy for septic shock on time to appropriate therapy for Candida infection: a pilot study","volume":"36","author":"Micek","year":"2014","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B97","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/jac\/dkq216","article-title":"A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients","volume":"65","author":"Hsu","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B98","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/CCM.0000000000000221","article-title":"Impact of therapeutic strategies on the prognosis of candidemia in the ICU","volume":"42","author":"Puig-Asensio","year":"2014","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B99","doi-asserted-by":"crossref","first-page":"117 e1","DOI":"10.1016\/j.cmi.2016.10.001","article-title":"Antifungal therapy for patients with proven or suspected Candida peritonitis: Amarcand2, a prospective cohort study in French intensive care units","volume":"23","author":"Montravers","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B100","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1186\/cc4869","article-title":"Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies","volume":"10","author":"Falagas","year":"2006","journal-title":"Crit Care"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B101","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1471-2334-11-261","article-title":"Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome","volume":"11","author":"Reboli","year":"2011","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B102","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10096-015-2527-2","article-title":"Initial antifungal strategy does not correlate with mortality in patients with candidemia","volume":"35","author":"Murri","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B103","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1469-0691.2012.03784.x","article-title":"Anidulafungin for the treatment of candidaemia\/invasive candidiasis in selected critically ill patients","volume":"18","author":"Ruhnke","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B104","doi-asserted-by":"crossref","first-page":"R253","DOI":"10.1186\/cc10514","article-title":"Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis","volume":"15","author":"Kett","year":"2011","journal-title":"Crit Care"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13054-015-0758-3","article-title":"Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients study","volume":"19","author":"Sinnollareddy","year":"2015","journal-title":"Crit Care"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20180313122809_dkx445-B106","doi-asserted-by":"crossref","first-page":"i44","DOI":"10.1093\/jac\/dkx448","article-title":"We can do better: a fresh look at echinocandin dosing","volume":"73","author":"Bader","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20180313122809_dkx445-B107","doi-asserted-by":"crossref","first-page":"i33","DOI":"10.1093\/jac\/dkx447","article-title":"Overview of antifungal dosing in invasive candidiasis","volume":"73","author":"Pea","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B108","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/cid\/cis305","article-title":"Septic shock attributed to Candida infection: importance of empiric therapy and source control","volume":"54","author":"Kollef","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B109","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/jac\/dks482","article-title":"Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study","volume":"68","author":"Eschenauer","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B110","doi-asserted-by":"crossref","first-page":"733.e1","DOI":"10.1016\/j.cmi.2016.05.008","article-title":"Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score-derived analysis of a population-based, multicentre prospective cohort","volume":"22","author":"Lopez-Cortes","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B111","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1128\/AAC.00195-16","article-title":"Propensity score analysis of the role of initial antifungal therapy in the outcome of Candida glabrata bloodstream infections","volume":"60","author":"Puig-Asensio","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B112","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00134-014-3310-z","article-title":"A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality","volume":"40","author":"Bassetti","year":"2014","journal-title":"Intensive Care Med"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B113","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00134-015-4053-1","article-title":"Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data","volume":"41","author":"Bailly","year":"2015","journal-title":"Intensive Care Med"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B114","doi-asserted-by":"crossref","first-page":"97.","DOI":"10.1186\/1471-2334-14-97","article-title":"Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial","volume":"14","author":"Vazquez","year":"2014","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4939-6515-1_5","article-title":"Systemic antifungal agents: current status and projected future developments","volume":"1508","author":"Seyedmousavi","year":"2017","journal-title":"Methods Mol Biol"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B116","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","article-title":"Echinocandin antifungal drugs","volume":"362","author":"Denning","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B117","doi-asserted-by":"crossref","first-page":"S622","DOI":"10.1093\/cid\/civ746","article-title":"Role of echinocandins in fungal biofilm-related disease: vascular catheter-related infections, immunomodulation, and mucosal surfaces","volume":"61","author":"Katragkou","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B118","author":"Rubino","year":"2015"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B119","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ja.2016.89","article-title":"CD101, a novel echinocandin with exceptional stability properties and enhanced aqueous solubility","volume":"70","author":"Krishnan","year":"2017","journal-title":"J Antibiot (Tokyo)"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B120","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/cmi.12640","article-title":"CD101: a novel long-acting echinocandin","volume":"18","author":"Zhao","year":"2016","journal-title":"Cell Microbiol"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B121","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.1128\/AAC.00701-16","article-title":"Preclinical evaluation of the stability, safety, and efficacy of CD101, a novel echinocandin","volume":"60","author":"Ong","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B122","author":"Ong","year":"2017"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B123","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1093\/jac\/dkw214","article-title":"Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates","volume":"71","author":"Pfaller","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B124","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/cid\/ciu407","article-title":"FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia","volume":"59","author":"Beyda","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B125","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01627-16","article-title":"Safety and pharmacokinetics of CD101 IV, a novel echinocandin, in healthy adults","volume":"61","author":"Sandison","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B126","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01626-16","article-title":"Pharmacokinetics of the novel echinocandin CD101 in multiple animal species","volume":"61","author":"Ong","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B128","author":"Cidara Therapeutics, Inc","year":"2016"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B129","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1128\/AAC.04445-14","article-title":"Pharmacodynamic target evaluation of a novel oral glucan synthase inhibitor, SCY-078 (MK-3118), using an in vivo murine invasive candidiasis model","volume":"59","author":"Lepak","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B130","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02068-16","article-title":"Preclinical pharmacokinetics and pharmacodynamic target of SCY-078, a first-in-class orally active antifungal glucan synthesis inhibitor, in murine models of disseminated candidiasis","volume":"61","author":"Wring","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B131","author":"Scynexis, Inc"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B132","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/jac\/dkq177","article-title":"Uptake of T-2307, a novel arylamidine, in Candida albicans","volume":"65","author":"Nishikawa","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B133","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/jac\/dkv398","article-title":"The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against echinocandin-resistant Candida glabrata","volume":"71","author":"Wiederhold","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B134","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1128\/CMR.00091-13","article-title":"Molecular and nonmolecular diagnostic methods for invasive fungal infections","volume":"27","author":"Arvanitis","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B135","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00204-016-1916-3","article-title":"New developments and directions in the clinical application of the echinocandins","volume":"91","author":"Chang","year":"2017","journal-title":"Arch Toxicol"},{"key":"key\n\t\t\t\t20180313122809_dkx445-B136","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01009-17","article-title":"Unraveling drug penetration of echinocandin antifungals at the site of infection in an intra-abdominal abscess model","volume":"61","author":"Zhao","year":"2017","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/suppl_1\/i14\/24332242\/dkx445.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T03:03:55Z","timestamp":1751079835000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/suppl_1\/i14\/4769694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,1]]},"references-count":136,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2018,1,3]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx445","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2018,1,1]]}}}